Biogen Reports Second Quarter 2023 Results

Biogen Appoints Jane Grogan as Head of Research

CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the appointment of Jane Grogan, Ph.D., as Executive Vice President, Head of Research effective 2 October 2023. Dr. Grogan will be a member of Biogen’s Executive Committee reporting to Christopher A.

Biogen to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Cambridge, MA, - -  Biogen Inc.   (Nasdaq: BIIB) announced today that Christopher Viehbacher, CEO, will participate in the Morgan Stanley 21 st Annual Global Healthcare Conference. The webcast will be live on Monday, Sept 11, 2023, at 10:40 a.m. ET. To access the live webcast, please visit the